Position in ROIV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,789,641
New position
Shares Held
64,608
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALLSTATE CORP holds $61,025,515 across 41 Biotechnology names. ROIV ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,523 | $9,610,880 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,953 | $8,462,725 | |
| 3 | INSM |
INSMED Inc
|
23,888 | $3,906,165 | |
| 4 | RPRX |
Royalty Pharma plc
|
57,398 | $2,753,382 | |
| 5 | MRNA |
Moderna, Inc.
|
41,326 | $2,099,360 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,335 | $2,096,061 | |
| 7 | INCY |
Incyte Corp
|
22,098 | $2,079,863 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
64,608 | $1,789,641 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,789,641 | 64,608 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||